Sophia Humphreys, PharmD, MHA, BCBBS, discusses common barriers to cancer therapy and how care teams can assist patients in ...

Lisa Taylor-Swanson, PhD, explains how including Indigenous and Hispanic women in conversations around menopause care helps fine-tune interventions. How do clinicians balance evidence-based practices ...

Up to 4 million people may lose coverage, increasing uninsured rates, especially in non-Medicaid expansion states and among ...

A machine learning model using basic clinical data can predict PH risk, identifying key predictors like low hemoglobin and elevated NT-proBNP. Researchers have developed a machine learning model that ...

Soft tissue sarcomas (STS) are rare malignant tumors arising from connective tissues such as muscle, fat, and blood vessels, ...

New methods of testing tissue and plasma beyond next-generation sequencing (NGS) could be used to deliver the best ...

Individuals in Michigan with low incomes and health problems were more likely to have employment gains when they were covered with Medicaid, which could have implications when work requirements change ...

Testosterone therapy lacks evidence for preventing muscle loss, bone fractures, heart disease, or cognitive decline in women.

MBS significantly reduces liver-related complications and other health risks in patients with SLD, including cardiovascular, ...

Marcus Flores, PharmD, BCPS, BCOP, discusses the vital role of pharmacists in multidisciplinary cancer care, exploring ...

US-based patients with idiopathic pulmonary fibrosis (IPF) had a slower decline in forced vital capacity (FVC) when they received nerandomilast (Jascayd; Boehringer Ingelheim) compared with placebo, a ...

Panelists discuss how schizophrenia presents a wide spectrum of symptoms categorized into positive, negative, and cognitive ...